Table 2. Clinical parameters of participants.
| Parameters | HBC | CHB | Healthy |
|---|---|---|---|
| Individuals (n) | 107 | 84 | 43 |
| Male | 61 | 49 | 23 |
| Female | 46 | 35 | 20 |
| Age (years) | 38.1±13.4 | 38.5±12.2 | 36.7±11.9 |
| ALT (IU/L) | 49.1(15-122) | 73.7(14-525) | 20.3(10-31) |
| AST (IU/L) | 56.0(19-187) | 52.7(16-353) | 19.9(14-35) |
| GGT (IU/L) | 43.4(14-131) | 48.8(10-284) | 21.3(14-27) |
| ALP (IU/L) | 170.6(33-1206) | 83.2(31-186) | 55.4(42-96) |
| TBIL (μM/L) | 35.0(16-84) | 18.7(5-44.8) | 14.9(9.8-20.5) |
| HBV DNA | 39960948 (0-94800000) |
14054341 (0-253200000) |
0 |
| HBV status (n) | |||
| HBsAg + | 107 | 84 | 0 |
| HBsAg - | 0 | 0 | 43 |
| Compensation | 75 | ||
| Decompensation | 32 |
Ages are given as mean ± S.D.; Values of alanine aminotransferase (ALT), aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL) and hepatitis B virus (HBV) DNA were given as medians (range); CHB: chronic hepatitis B; HBsAg: hepatitis B surface antigen.